ATE538385T1 - Auf der oberfläche von apikomplexparasiten exponiertes digalaktolipidantigen sowie seine diagnostische und therapeutische verwendung - Google Patents

Auf der oberfläche von apikomplexparasiten exponiertes digalaktolipidantigen sowie seine diagnostische und therapeutische verwendung

Info

Publication number
ATE538385T1
ATE538385T1 AT08761852T AT08761852T ATE538385T1 AT E538385 T1 ATE538385 T1 AT E538385T1 AT 08761852 T AT08761852 T AT 08761852T AT 08761852 T AT08761852 T AT 08761852T AT E538385 T1 ATE538385 T1 AT E538385T1
Authority
AT
Austria
Prior art keywords
digalactolipid
parasites
diagnostic
directed against
therapeutic use
Prior art date
Application number
AT08761852T
Other languages
English (en)
Inventor
Cyrille Botte
Nadia Saidani
Maryse Block
Jean-Francois Dubremetz
Henri Vial
Marie-France Cesbron-Delauw
Corinne Mercier
Eric Marechal
Original Assignee
Commissariat Energie Atomique
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Centre Nat Rech Scient filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE538385T1 publication Critical patent/ATE538385T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A61K39/018—Babesia antigens, e.g. Theileria antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT08761852T 2007-02-07 2008-02-07 Auf der oberfläche von apikomplexparasiten exponiertes digalaktolipidantigen sowie seine diagnostische und therapeutische verwendung ATE538385T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0700859A FR2912218A1 (fr) 2007-02-07 2007-02-07 Antigene digalactolipidique expose a la surface des parasites apicomplexes et ses applications diagnostiques et therapeutiques
PCT/FR2008/000149 WO2008107572A1 (fr) 2007-02-07 2008-02-07 Antigene digalactolipidique expose a la surface des parasites apicomplexes et ses applications diagnostiques et therapeutiques

Publications (1)

Publication Number Publication Date
ATE538385T1 true ATE538385T1 (de) 2012-01-15

Family

ID=38291032

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08761852T ATE538385T1 (de) 2007-02-07 2008-02-07 Auf der oberfläche von apikomplexparasiten exponiertes digalaktolipidantigen sowie seine diagnostische und therapeutische verwendung

Country Status (5)

Country Link
US (1) US20100040615A1 (de)
EP (1) EP2122357B1 (de)
AT (1) ATE538385T1 (de)
FR (1) FR2912218A1 (de)
WO (1) WO2008107572A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20155459A1 (it) 2015-11-11 2017-05-11 Fpt Ind Spa Metodo di controllo di erogazione di una coppia motrice di un motore di un trattore agricolo
CN108314735B (zh) * 2018-01-17 2021-05-18 华中农业大学 一种抗田鼠巴贝斯虫的单克隆抗体及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8038986B2 (en) * 2002-07-26 2011-10-18 The Walter And Eliza Hall Institute Of Medical Research Immunogenic compositions and diagnostic and therapeutic uses thereof

Also Published As

Publication number Publication date
FR2912218A1 (fr) 2008-08-08
US20100040615A1 (en) 2010-02-18
EP2122357A1 (de) 2009-11-25
EP2122357B1 (de) 2011-12-21
WO2008107572A1 (fr) 2008-09-12

Similar Documents

Publication Publication Date Title
Nikaeen et al. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses
Kolkhir et al. Chronic spontaneous urticaria and internal parasites–a systematic review
Puterman et al. Anger is associated with increased IL-6 stress reactivity in women, but only among those low in social support
MX342791B (es) Ensayo elisa para la detección de vegf.
EP3750916A3 (de) Monoklonale antikörper gegen das denguevirus-ns1-protein
Lee et al. Capture of the circulating Plasmodium falciparum biomarker HRP2 in a multiplexed format, via a wearable skin patch
EA201300125A1 (ru) Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии
Li et al. Sample-free quantification of blood biomarkers via laser-treated skin
RU2010101909A (ru) Способ выявления или лечения реакции "трансплантат против хозяина"
DE602005021644D1 (de) Verfahren und reagentien zur diagnose von hantavirusinfektionen
Wilkirson et al. Lateral flow-based skin patch for rapid detection of protein biomarkers in human dermal interstitial fluid
US10500412B2 (en) Devices, systems, and methods for inducing dermal blood vessel leakage
Roth et al. Biocompatibility and safety assessment of combined topical ozone and antibiotics for treatment of infected wounds
DE50304586D1 (de) Verfahren zur sepsisdiagnose durch bestimmung von anti-asialo-gangliosid-antikörpern
CN103728277A (zh) 用于结合有兴趣的标的物的装置与传感器及制造使用方法
Freire et al. Serum proteomic markers in patients with systemic sclerosis in relation to silica exposure
BR112021025089A2 (pt) Antígenos secretados inovadores para diagnóstico de infecção ativa por babesia microti e babesia duncani em humanos e animais
Thompson et al. Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees
DellaValle et al. Implementation of minimally invasive and objective humane endpoints in the study of murine Plasmodium infections
Kushawaha et al. Nipah virus and its outbreaks in tropical areas
WO2010108245A3 (pt) Uso de antígenos de leishmania em método diagnóstico, vacina e terapia para leishmaniose
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
CY1112415T1 (el) Η πρωτεϊνη serum amyloid p-component (sap, samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)
ATE513558T1 (de) Verfahren zur diagnose und/oder überwachung von invasiver aspergillose
Wu et al. Laser‐induced capillary leakage for blood biomarker detection and vaccine delivery via the skin